One Case Closes, Another Opens

Unsure of the origins of a rogue crop found on an Oregon farm, the US Department of Agriculture is following up on a second issue related to genetically engineered wheat.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, DAVID MONNIAUXAfter months of investigation, the United States Department of Agriculture (USDA) has closed the case of the genetically engineered (GE) wheat an Oregon farmer mysteriously found growing in his fields last year. In a September 26 statement, the USDA Animal and Plant Health Inspection Service (APHIS) said it had “concluded that the presence of the GE wheat”—a variety called Roundup Ready, produced by Monsanto to be resistant to its herbicide Roundup—“appears to be an isolated incident.” In its investigation, the agency found no evidence that the modified wheat had entered the marketplace—a finding APHIS said was “critical . . . to trading partners to keep foreign wheat markets open.”

How the plant arrived on the farm remains a mystery, however. “After exhausting all leads, APHIS was unable to determine exactly how the GE wheat came to grow in the farmer’s field,” the agency said.

The agency added that it’s now investigating the appearance of GE wheat at Montana State University’s Southern Agricultural Research Center, where the crop was grown as part of government-approved field trials from 2000 to 2003. APHIS said the appearance of Monsanto’s Roundup Ready wheat in the two states were isolated incidents.

Hat tip: NPR’s The Salt

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies